Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.
Pusceddu S, Corti F, Prinzi N, Nichetti F, Ljevar S, Busico A, Cascella T, Leporati R, Oldani S, Pircher CC, Coppa J, Resi V, Milione M, Maccauro M, Miceli R, Tamborini E, Perrone F, Spreafico C, Niger M, Morano F, Pietrantonio F, Seregni E, Mariani L, Mazzaferro V, Di Liberti G, Fucà G, de Braud F, Vernieri C. Pusceddu S, et al. Among authors: corti f. J Hematol Oncol. 2023 Dec 14;16(1):119. doi: 10.1186/s13045-023-01510-9. J Hematol Oncol. 2023. PMID: 38098114 Free PMC article. Clinical Trial.
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs.
Prinzi N, Raimondi A, Maccauro M, Milione M, Garanzini E, Torchio M, Corti F, Nichetti F, Lo Russo G, Giacomelli L, Mazzaferro V, Di Bartolomeo M, Seregni E, de Braud F, Pusceddu S. Prinzi N, et al. Among authors: corti f. Future Oncol. 2019 Sep;15(26):3015-3024. doi: 10.2217/fon-2019-0138. Epub 2019 Aug 19. Future Oncol. 2019. PMID: 31424273
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence.
Pusceddu S, Vernieri C, Prinzi N, Torchio M, Coppa J, Antista M, Niger M, Milione M, Giacomelli L, Corti F, Prisciandaro M, Monteleone M, Colombo E, Di Bartolomeo M, de Braud F. Pusceddu S, et al. Among authors: corti f. Therap Adv Gastroenterol. 2020 Jul 31;13:1756284820927271. doi: 10.1177/1756284820927271. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32821286 Free PMC article. Review.
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches.
Niger M, Prisciandaro M, Antista M, Monica MAT, Cattaneo L, Prinzi N, Manglaviti S, Nichetti F, Brambilla M, Torchio M, Corti F, Pusceddu S, Coppa J, Mazzaferro V, de Braud F, Di Bartolomeo M. Niger M, et al. Among authors: corti f. World J Gastrointest Oncol. 2020 Aug 15;12(8):833-849. doi: 10.4251/wjgo.v12.i8.833. World J Gastrointest Oncol. 2020. PMID: 32879662 Free PMC article. Review.
Target therapies plus somatostatin analogs in NETs: a network meta-analysis.
Pusceddu S, Facciorusso A, Giacomelli L, Prinzi N, Corti F, Niger M, Milione M, Coppa J, Cascella T, Pulice I, Biamonte L, Papa S, Di Bartolomeo M, Shah A, Sacco R, de Braud F. Pusceddu S, et al. Among authors: corti f. Endocr Relat Cancer. 2021 Jun 17;28(7):467-479. doi: 10.1530/ERC-20-0492. Endocr Relat Cancer. 2021. PMID: 33979777
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study.
Pusceddu S, Vernieri C, Di Maio M, Prinzi N, Torchio M, Corti F, Coppa J, Buzzoni R, Di Bartolomeo M, Milione M, Regnault B, Truong Thanh XM, Mazzaferro V, de Braud F. Pusceddu S, et al. Among authors: corti f. Cancers (Basel). 2021 Dec 23;14(1):69. doi: 10.3390/cancers14010069. Cancers (Basel). 2021. PMID: 35008233 Free PMC article.
192 results